| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/24/2009 | CA2718936A1 Novel heterocyclic compounds and uses therof |
| 09/24/2009 | CA2718736A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | CA2718264A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | CA2716694A1 Process |
| 09/23/2009 | EP2103603A1 Method for producing pyrrolidine compound |
| 09/23/2009 | EP2102181A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 09/23/2009 | EP2102171A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 09/23/2009 | EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 09/23/2009 | EP2102157A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 09/23/2009 | EP1709003B1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/23/2009 | CN101538288A Monomer for organic electro-phosphorescent polymer |
| 09/23/2009 | CN101538265A Diaryl vinyl group-containing amphiphilic compound and preparation method and applications thereof |
| 09/22/2009 | US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 09/22/2009 | US7592364 Substituted gamma lactams as therapeutic agents |
| 09/22/2009 | US7592358 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 09/22/2009 | US7592357 Compounds |
| 09/22/2009 | US7592346 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/22/2009 | US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2009 | CA2474627C R-(-)-1-[2-(7-chlorobenzo[b]thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1h-imidazole |
| 09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/17/2009 | WO2009114307A1 Therapeutic compounds |
| 09/17/2009 | WO2009113600A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | WO2009113322A1 Photodissociable protective group |
| 09/17/2009 | WO2009112854A1 Compounds having electroluminescent or electron transport properties |
| 09/17/2009 | WO2009112845A1 Amido-thiophene compounds and their use |
| 09/17/2009 | WO2009112533A1 Substituted triazinylmethyl sulfonamides |
| 09/17/2009 | WO2009112523A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 09/17/2009 | WO2009112490A1 Sulfonamides as zap-70 inhibitors |
| 09/17/2009 | WO2009112155A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 09/17/2009 | WO2009111893A1 Substituted pyrimidine compounds and their use as ifnar mediators |
| 09/17/2009 | US20090233980 Substituted gamma lactams as therapeutic agents |
| 09/17/2009 | US20090233965 Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive Bladder |
| 09/17/2009 | US20090233920 Organic compounds |
| 09/17/2009 | US20090233901 Vla-4 inhibitory drug |
| 09/17/2009 | US20090231678 Electro-optic chromophore having an edot structure, and related methods and apparatuses |
| 09/17/2009 | CA2718393A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | CA2717632A1 Therapeutic compounds |
| 09/17/2009 | CA2717529A1 Sulfonamides as zap-70 inhibitors |
| 09/17/2009 | CA2716679A1 Amido-thiophene compounds and their use |
| 09/16/2009 | EP2101365A1 Organic electroluminescent device, display and illuminating device |
| 09/16/2009 | EP2099791A1 Thienyl-containing glycopyranosyl derivatives as antidiabetics |
| 09/16/2009 | EP2099789A1 Inhibitors of hiv replication |
| 09/16/2009 | EP2099774A1 Inhibitors of kinase activity |
| 09/16/2009 | EP2099770A2 Pyridazinones and furan-containing compounds |
| 09/16/2009 | EP2099767A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof |
| 09/16/2009 | EP2099765A2 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 09/16/2009 | EP2099763A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 09/16/2009 | EP2099762A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099760A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099757A2 Sulfoximines as kinase inhibitors |
| 09/16/2009 | EP2099753A2 Heteroarylacrylamides and their use as pharmaceuticals |
| 09/16/2009 | EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 09/16/2009 | EP1478364B1 Selective antibacterial agents |
| 09/16/2009 | EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 09/16/2009 | CN101535303A Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level |
| 09/16/2009 | CN101531686A Monomer for organic electrophosphorescent polymer |
| 09/16/2009 | CN101531685A Monomer for organic electrophosphorescent polymer |
| 09/16/2009 | CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589213 Therapeutic substituted lactams |
| 09/15/2009 | US7589207 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589120 N-[[4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-thienyl]methyl]-4-(trifluoromethyl)benzenesulfonamide; antagonist properties with regard to CB1 cannabinoid receptors |
| 09/15/2009 | US7589116 Biaryl substituted pyrazoles as sodium channel blockers |
| 09/15/2009 | US7589112 Methylene urea derivatives |
| 09/15/2009 | US7589111 Antitumor agents; improved efficacy and less toxicity; taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3' and an isopropoxycarbamate substituent at C3'. |
| 09/15/2009 | US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors |
| 09/15/2009 | US7589103 Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | CA2522323C 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands |
| 09/15/2009 | CA2464289C Heterocyclic retinoid compounds |
| 09/15/2009 | CA2429220C Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 09/15/2009 | CA2409819C Triazole derivatives |
| 09/11/2009 | WO2009111447A2 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/11/2009 | WO2009111417A1 Substituted beta-lactams |
| 09/11/2009 | WO2009110468A1 Potassium channel opener |
| 09/11/2009 | WO2009109546A1 Photochromic dichroic naphtho-pyrans and optical articles containing them |
| 09/11/2009 | WO2009109491A1 2-aminoquinoline derivatives |
| 09/11/2009 | WO2009021126A9 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 09/11/2009 | WO2008001931A3 Fused cyclic compounds |
| 09/11/2009 | CA2716741A1 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/11/2009 | CA2715842A1 2-aminoquinoline derivatives |
| 09/11/2009 | CA2625306A1 Electron acceptors-cored regioregular oligothiophenes as building blocks for soluble low band-gap conjugated polymers |
| 09/10/2009 | US20090227799 Novel Antimalarial Agent Containing Heterocyclic Compound |
| 09/10/2009 | US20090227795 Target molecules of pladienolides, compounds binding to such target molecules, and screening method thereof |
| 09/10/2009 | US20090227789 Ethylenediamine derivatives |
| 09/10/2009 | US20090227653 Substituted gamma lactams as therapeutic agents |
| 09/10/2009 | US20090227636 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension |